Multifactorial Analysis Identifies Conditions for Robust HCoV-OC43 Replication in Primary Human Bronchial Epithelial Cells Cultured at Air-Liquid Interface. [PDF]
Fischhaber N +3 more
europepmc +1 more source
Fisetin as an Antiviral Agent Targeting the RNA-Dependent RNA Polymerase of SARS-CoV-2: Computational Prediction and In Vitro Experimental Validation. [PDF]
Hernández-Rodríguez X +15 more
europepmc +1 more source
Genetic complementation reveals structure-function links in nodavirus RNA replication complex crowns. [PDF]
den Boon JA +6 more
europepmc +1 more source
Phosphorylation Modifications and Their Role in Viral Pneumonia: Mechanisms and Therapeutic Implications. [PDF]
Wang L, Zhang H, Jiang H.
europepmc +1 more source
In Vitro Analysis and Dynamic Modeling of SARS-CoV-2 Infection Inhibition by Sigma-1 Receptor Antagonist PB28. [PDF]
Lisowski B +4 more
europepmc +1 more source
Aerosolization effects on coronavirus infectivity. [PDF]
Zhang M, Hamer GL, King MD.
europepmc +1 more source
Gene expression profiles of Protein tyrosine phosphatase non-receptor 22, Tumor necrosis factor receptor-associated factor 1 and Interleukin-1 beta in patients with rheumatoid arthritis and healthy controls after severe acute respiratory syndrome-associated coronavirus-2 infection or vaccination. [PDF]
Sanguor MH +4 more
europepmc +1 more source
Decoding the Structural Complexity of Viral RNAs with SHAPE to Guide Antiviral Therapeutics. [PDF]
Broglia L +4 more
europepmc +1 more source
Selon l’université Johns Hopkins, plus de 600 millions de cas de coronavirus 2019 (COVID - 19) infectés par le SRAS-CoV-2 ont été signalés dans le monde depuis décembre 2019. La COVID-19 a causé une catastrophe énorme dans le monde, tuant plus de six millions de personnes. Il est donc essentiel de trouver des médicaments ou des vaccins efficaces. L'ARN
openaire +1 more source
Development and Evaluation of Molecular Diagnostic Tests for SARS-CoV-2 at English NHS Sites Throughout the COVID-19 Pandemic. [PDF]
Griffith LD, Dervisevic S, Powell PP.
europepmc +1 more source

